Adjuvant chemotherapy in the elderly

Annals of Oncology

Volumn 14, Issue SUPPL. 3, 2003, Pages

  Biganzoli, L ^a   Aapro, M ^b  

^a JULES BORDET INSTITUTE   (Belgium)

^b CLINIQUE DE GENOLIER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; METHOTREXATE; NAVELBINE; TAMOXIFEN; TAXANE DERIVATIVE;

ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL TRIAL; COLON CANCER; COMORBIDITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TARGETING; DRUG TOLERABILITY; DRUG TOLERANCE; FAMILY HISTORY; FEMALE; GERIATRICS; HUMAN; LIFE EXPECTANCY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0037622579     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg740     Document Type: Article

References (27)

1. Alberg AJ, Singh S. Epidemiology of breast cancer in older women: implications for future healthcare. Drugs Aging 2001; 18: 761-772.
2. Facts and figures about cancer clinical trials. http://www.nci.nih.gov/clinicaltrials/facts-and-figures
3. Monfardini S, Sorio R, Boes GH et al. Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studies. Cancer 1995; 76: 333-338.
4. Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 1983; 52: 1986-1992.
5. Dhodapkar MV, Ingle JN, Cha SS et al. Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective trials. Cancer 1996; 77: 683-690.
6. Siu LL, Shepherd FA, Murray N et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996; 14: 821-828.
7. Bush E, Kemeny M, Fremgen A et al. Patterns of breast cancer care in the elderly. Cancer 1996; 78: 101-111.
8. Bergman L, Kluck HM, van Leeuwen FE et al. The influence of age on treatment choice and survival of elderly breast cancer patients in southeastern Netherlands: a population-based study. Eur J Cancer 1992; 28A: 235-244.
9. Goodwin JS, Samet JM, Hurt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst 1996; 88: 1031-1037.
10. Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst 1993; 85: 1580-1584.
11. Higtower RD, Nguyen HN, Averette HE et al. National survey of ovarian carcinoma. IV: Patterns of care and related survival for older patients. Cancer 1994; 73: 377-383.
12. Newschaffer CJ, Penberthy L, Desch CE et al. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. Arch Intern Med 1996; 156: 85-90.
13. Castiglione M, Gelber RD, Goldhirsch A. Adjuvant systematic therapy for breast cancer in the elderly: competing causes of mortality. J Clin Oncol 1990; 8: 519-526.
14. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 92: 550-556.
15. Fish EB, Chapman JA, Link MA. Competing causes of death for primary breast cancer. Ann Surg Oncol 1998; 5: 368.
16. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000; 5: 224-237.
17. Alessi CA, Stuck AE, Aronow HU et al. The process of care in preventive in-home comprehensive geriatric assessment. J Am Geriatr Soc 1997; 45: 1044-1050.
18. Gillespie LD, Gillespie WJ, Roberts MC et al. Interventions for preventing falls in the elderly. Cochrane Library 2003; CD000340. http://www.cochrane.org (13 May 2003, date last accessed).
19. Repetto L, Fratino L, Audisio RA et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology study. J Clin Oncol 2002; 20: 494-502.
20. Zagonel V, Fratino L, Piselli P et al. The comprehensive geriatric assessment (CGA) predicts mortality among elderly cancer patients (ECP). Proc Am Soc Clin Oncol 2002; 21: 365a (Abstr 1458).
21. Extermann M, Balducci L, Lyman GH. What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 2000; 8: 1709-1717.
22. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998; 352: 930-942.
23. Fargeot P, Roche H, Bonneterre JM et al. Disease-free survival (DFS) advantage of weekly epirubicin plus tamoxifen vs tamoxifen (Tam) alone as adjuvant treatment of operable, node-positive (N+) elderly breast cancer (BC) patient (pts): 5 year-follow-up results of French adjuvant study group, FASG-08 trial. Proc Am Soc Clin Oncol 2002; 21: 37a (Abstr 145).
24. Biganzoli L, Goldhirsch A, Straehle C et al. Breast International Group (BIG) survey of medical oncologist attitudes to the management of elderly patients (pts) with early breast cancer (BC). Ann Oncol 2002; 13 (Suppl 5): 105 (Abstr 380P).
25. Sargent DJ, Goldberg RM, Jacobson SD et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345: 1091-1097.
26. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002; 20: 3992-3998.
27. Crivellari D, Bonetti M, Castiglione-Gertsch M et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 2000; 18: 1412-1422.